Taiwan · Delayed Price · Currency is TWD GeneFerm Biotechnology Statistics
Total Valuation
TPEX:1796 has a market cap or net worth of TWD 1.43 billion. The enterprise value is 1.47 billion.
| Market Cap | 1.43B |
| Enterprise Value | 1.47B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
TPEX:1796 has 41.46 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 41.46M |
| Shares Outstanding | 41.46M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 9.52% |
| Owned by Institutions (%) | n/a |
| Float | 20.67M |
Valuation Ratios
The trailing PE ratio is 90.84.
| PE Ratio | 90.84 |
| Forward PE | n/a |
| PS Ratio | 2.15 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | 23.35 |
| P/OCF Ratio | 16.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.99, with an EV/FCF ratio of 24.05.
| EV / Earnings | 93.57 |
| EV / Sales | 2.21 |
| EV / EBITDA | 13.99 |
| EV / EBIT | 46.68 |
| EV / FCF | 24.05 |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.41.
| Current Ratio | 3.24 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 5.27 |
| Interest Coverage | 5.02 |
Financial Efficiency
Return on equity (ROE) is 1.99% and return on invested capital (ROIC) is 2.89%.
| Return on Equity (ROE) | 1.99% |
| Return on Assets (ROA) | 1.57% |
| Return on Invested Capital (ROIC) | 2.89% |
| Return on Capital Employed (ROCE) | 2.90% |
| Weighted Average Cost of Capital (WACC) | 4.16% |
| Revenue Per Employee | 4.61M |
| Profits Per Employee | 109,028 |
| Employee Count | 144 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, TPEX:1796 has paid 4.63 million in taxes.
| Income Tax | 4.63M |
| Effective Tax Rate | 22.79% |
Stock Price Statistics
The stock price has decreased by -21.20% in the last 52 weeks. The beta is 0.09, so TPEX:1796's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -21.20% |
| 50-Day Moving Average | 35.46 |
| 200-Day Moving Average | 44.05 |
| Relative Strength Index (RSI) | 50.34 |
| Average Volume (20 Days) | 30,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1796 had revenue of TWD 663.87 million and earned 15.70 million in profits. Earnings per share was 0.38.
| Revenue | 663.87M |
| Gross Profit | 176.67M |
| Operating Income | 31.47M |
| Pretax Income | 20.33M |
| Net Income | 15.70M |
| EBITDA | 97.86M |
| EBIT | 31.47M |
| Earnings Per Share (EPS) | 0.38 |
Balance Sheet
The company has 278.95 million in cash and 321.81 million in debt, with a net cash position of -42.86 million or -1.03 per share.
| Cash & Cash Equivalents | 278.95M |
| Total Debt | 321.81M |
| Net Cash | -42.86M |
| Net Cash Per Share | -1.03 |
| Equity (Book Value) | 781.43M |
| Book Value Per Share | 18.85 |
| Working Capital | 399.15M |
Cash Flow
In the last 12 months, operating cash flow was 86.31 million and capital expenditures -25.22 million, giving a free cash flow of 61.09 million.
| Operating Cash Flow | 86.31M |
| Capital Expenditures | -25.22M |
| Depreciation & Amortization | 66.38M |
| Net Borrowing | -39.75M |
| Free Cash Flow | 61.09M |
| FCF Per Share | 1.47 |
Margins
Gross margin is 26.61%, with operating and profit margins of 4.74% and 2.36%.
| Gross Margin | 26.61% |
| Operating Margin | 4.74% |
| Pretax Margin | 3.06% |
| Profit Margin | 2.36% |
| EBITDA Margin | 14.74% |
| EBIT Margin | 4.74% |
| FCF Margin | 9.20% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 1.83%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 1.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 1.10% |
| FCF Yield | 4.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:1796 has an Altman Z-Score of 3.52 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.52 |
| Piotroski F-Score | 7 |